March 5th, 2020 /
In the News
NorthStar Expands Into Cardiac SPECT With New Licensing Deal
NorthStar Medical Technologies is moving further into the cardiac imaging space after signing a new licensing agreement with St. Louis-based Capella Imaging, the companies announced Tuesday.
As part of the deal, the Beloit, Wisconsin-based radioisotope company has acquired exclusive rights from Capella to develop and investigate a new fibrin-targeted diagnostic imaging agent used in single-photon emission computerized tomography (SPECT) exams. Read more…
Questions?
Do you have questions about NorthStar, our products, supply solutions, careers or anything else?
